Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43,056,667
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
32,686,703
-
Shares change
-
+3,624,763
-
Total reported value, excl. options
-
$689,483,446
-
Value change
-
+$73,866,430
-
Put/Call ratio
-
1.05%
-
Number of buys
-
37
-
Number of sells
-
-27
-
Price
-
$21.09
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q4 2021
83 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q4 2021.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,686,703 shares
of 43,056,667 outstanding shares and own 75.92% of the company stock.
Largest 10 shareholders include BVF INC/IL (4,858,761 shares), ORBIMED ADVISORS LLC (3,322,488 shares), FMR LLC (3,021,313 shares), ARK Investment Management LLC (2,980,836 shares), Redmile Group, LLC (2,789,496 shares), MPM ASSET MANAGEMENT LLC (2,242,636 shares), CHI Advisors LLC (2,212,256 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,166,822 shares), Deep Track Capital, LP (2,100,000 shares), and Logos Global Management LP (1,700,000 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.